Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergy.
Noguchi E, Akiyama M, Yagami A, Hirota T, Okada Y, Kato Z, Kishikawa R, Fukutomi Y, Hide M, Morita E, Aihara M, Hiragun M, Chinuki Y, Okabe T, Ito A, Adachi A, Fukunaga A, Kubota Y, Aoki T, Aoki Y, Nishioka K, Adachi T, Kanazawa N, Miyazawa H, Sakai H, Kozuka T, Kitamura H, Hashizume H, Kanegane C, Masuda K, Sugiyama K, Tokuda R, Furuta J, Higashimoto I, Kato A, Seishima M, Tajiri A, Tomura A, Taniguchi H, Kojima H, Tanaka H, Sakai A, Morii W, Nakamura M, Kamatani Y, Takahashi A, Kubo M, Tamari M, Saito H, Matsunaga K. Noguchi E, et al. Among authors: fukunaga a. J Allergy Clin Immunol. 2019 Nov;144(5):1354-1363. doi: 10.1016/j.jaci.2019.06.034. Epub 2019 Jul 10. J Allergy Clin Immunol. 2019. PMID: 31301374
Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria.
Hide M, Park HS, Igarashi A, Ye YM, Kim TB, Yagami A, Roh J, Lee JH, Chinuki Y, Youn SW, Lee SK, Inomata N, Choi JH, Fukunaga A, Wang J, Matsushima S, Greenberg S, Khalil S. Hide M, et al. Among authors: fukunaga a. J Dermatol Sci. 2017 Jul;87(1):70-78. doi: 10.1016/j.jdermsci.2017.03.009. Epub 2017 Mar 21. J Dermatol Sci. 2017. PMID: 28366435 Free article. Clinical Trial.
Efficacy and safety of omalizumab for the treatment of refractory chronic spontaneous urticaria in Japanese patients: Subgroup analysis of the phase 3 POLARIS study.
Hide M, Igarashi A, Yagami A, Chinuki Y, Inomata N, Fukunaga A, Kaiser G, Wang J, Matsushima S, Greenberg S, Khalil S. Hide M, et al. Among authors: fukunaga a. Allergol Int. 2018 Apr;67(2):243-252. doi: 10.1016/j.alit.2017.10.001. Epub 2017 Nov 1. Allergol Int. 2018. PMID: 29102514 Free article. Clinical Trial.
387 results